Madrid, Spain – May 11, 2026 – The inaugural edition of Pharma X Next Conference 2026, organized by Next Business Media, concluded successfully in Madrid, Spain, bringing together pharmaceutical executives, biotech innovators, healthcare leaders, researchers, AI experts, commercial strategists, and industry pioneers from across the global life sciences ecosystem.
Held under the theme “Transforming the Future of Pharma, Biotech & Healthcare,” the conference served as a dynamic platform for industry leaders to exchange insights, explore emerging technologies, discuss commercialization strategies, and address the future challenges and opportunities shaping healthcare worldwide.
The event featured over 18 international speakers, delegates from more than 12 countries, thought-provoking keynote presentations, expert-led sessions, panel discussions, networking opportunities, and the prestigious Pharma X Next Awards Ceremony.
Driving Innovation Across Pharma, Biotech and Healthcare
The conference focused on some of the most critical themes impacting the pharmaceutical and biotechnology industries today, including:
- Artificial Intelligence in Drug Discovery and Healthcare
- Pharmaceutical Commercial Excellence
- Oncology and Rare Disease Innovation
- Clinical Research and Real-World Evidence
- Market Access and Patient-Centric Healthcare
- Digital Transformation in Pharma
- Biotech Innovation and Emerging Technologies
- Supply Chain Transformation
- Sustainability and One Health
- Future Pharmaceutical Leadership
Opening the conference, Anas Jawed, CEO of Next Business Media, welcomed attendees and highlighted the importance of collaboration, innovation, and leadership in advancing the future of healthcare and life sciences.
Expert Speaker Sessions Deliver Actionable Industry Insights
Throughout the day, attendees gained valuable perspectives from renowned experts addressing the latest developments in pharmaceutical research, biotechnology, AI adoption, healthcare innovation, and commercial strategy.
Learning Chemistry Beyond Rules: From Fragments to Drug-like Molecules with Generative AI
Lisa Piazza (University of Pisa) explored how generative artificial intelligence is transforming medicinal chemistry and accelerating the creation of novel drug-like molecules. Her presentation demonstrated the growing impact of AI on pharmaceutical research and early-stage drug discovery.
Clinical Trials & Case Studies
Alfonso García Cañamaque shared practical experiences and lessons learned from clinical research projects, discussing opportunities to improve trial efficiency, innovation, and patient outcomes through data-driven approaches.
AI Compliance Master-Class in Pharma: Mapping the Intersection of Laws, Standards, and Governance
Nikodem Latocha provided an in-depth overview of the evolving regulatory and compliance landscape surrounding artificial intelligence in pharmaceutical organizations. The session focused on governance frameworks, risk management, and responsible AI implementation.
SILCS: Combining Physics-Based Data and AI for Drug Design and Development
Dr. Alexander MacKerell showcased how the combination of physics-based modeling and artificial intelligence is creating new opportunities for more effective drug discovery and development processes.
From Alpha to Omega: AI-Powered Advanced 3D Cellular Models in Drug Discovery
Alessandro Scandurra demonstrated how advanced AI-powered 3D cellular models are enabling researchers to better understand disease mechanisms and accelerate therapeutic development.
The Future of Pharma: Expert Insights
Panelists:
The panel explored major trends influencing the future of pharmaceuticals, including AI adoption, digital transformation, patient-centric healthcare, commercialization strategies, and leadership in a rapidly evolving healthcare environment.
Innovating Pharma Supply Chains: From AI-Driven Strategy to Global Distribution
Panelists:
This discussion focused on how artificial intelligence, predictive analytics, and digital technologies are strengthening pharmaceutical supply chains, improving operational resilience, and enabling more efficient global distribution networks.
How Social Media Listening Combined with AI is Revolutionizing the Pharma and Medical World
Francisco Javier Domingo highlighted how AI-powered social listening tools are helping pharmaceutical and healthcare organizations gain deeper insights into patient sentiment, healthcare trends, stakeholder engagement, and market intelligence.
Innovation vs. Necessity: Is Digitalization Always the Answer in Clinical Research?
Dr. Marek Wasiluk encouraged attendees to critically evaluate digital transformation initiatives in clinical research, emphasizing the importance of balancing innovation with real-world value and patient needs.
Beyond the Pill: Scaling AI in Drug Discovery, MedTech and Commercial Excellence
Alejandro Villaveces explored how artificial intelligence is creating measurable impact across drug discovery, medical technology, and pharmaceutical commercial operations.
Next Generation RWE (AI & Living Evidence Hubs, The New Generation of RWE)
Dr. Ignacio H. Medrano presented innovative approaches to real-world evidence generation through AI-powered systems and living evidence hubs, highlighting their potential to improve healthcare decision-making and patient outcomes.
Stability Studies in Brazil (Zone IVB) of Medicines and Food Supplements
Ana Augusta Lemos shared valuable regulatory and quality assurance insights related to stability testing requirements for pharmaceutical products and food supplements in Brazil’s climatic Zone IVB.
Protecting Pollinators: The Overlooked Pillar of Global Food Security and One Health
Dr. Miguel Ángel Rodríguez Ramos delivered a compelling presentation on the importance of pollinators in sustaining biodiversity, food security, environmental sustainability, and public health, reinforcing the importance of the One Health approach.
Meaningful Industry Discussions and Global Networking
In addition to the speaker sessions, attendees participated in engaging discussions surrounding:
- Future trends in biotechnology
- AI-driven pharmaceutical innovation
- Commercial excellence and market access
- Patient access and healthcare equity
- Oncology and rare disease advancements
- Sustainable healthcare ecosystems
- Leadership in global pharmaceutical organizations
- Digital transformation and data-driven healthcare
The networking sessions provided valuable opportunities for industry leaders, innovators, researchers, and decision-makers to establish new connections, exchange ideas, and explore future collaborations.
Celebrating Excellence: Pharma X Next Awards 2026
A key highlight of the conference was the Pharma X Next Awards Ceremony, recognizing exceptional individuals whose leadership and innovation are shaping the future of healthcare and life sciences.
Excellence in Pharma Industry for Strategic Leadership in Oncology & Biotech
Winner: Serena Saggini
Serena Saggini was recognized for her outstanding contributions to oncology commercialization, rare diseases, biotech growth, patient-centric healthcare strategies, and pharmaceutical leadership. Her impact across the pharmaceutical and biotechnology sectors continues to drive innovation and business transformation.
Excellence in Pharmaceutical Industry – Leaders – Veterinary Pharma & One Health Innovation
Winner: Dr. Miguel Ángel Rodríguez Ramos
Dr. Miguel Ángel Rodríguez Ramos received recognition for his remarkable contributions to veterinary pharmaceuticals, international business development, sustainability initiatives, and One Health innovation. His work continues to strengthen collaboration between human health, animal health, and environmental sustainability.
A Successful First Edition
Pharma X Next Conference 2026 successfully established itself as a global platform dedicated to advancing innovation, leadership, and collaboration across the pharmaceutical, biotechnology, healthcare, and life sciences industries.
The event received overwhelmingly positive feedback from attendees who praised the quality of speakers, relevance of topics, practical insights, and networking opportunities.
Looking Ahead: Pharma X Next Conference 2027
Building on the success of its inaugural edition, the second edition of Pharma X Next Conference has officially been announced.
Pharma X Next Conference 2027 will take place on March 11–12, 2027, in Rome, Italy.
The upcoming edition will continue bringing together pharmaceutical executives, biotech innovators, healthcare leaders, researchers, digital transformation experts, and industry pioneers to discuss the technologies, strategies, and innovations shaping the future of healthcare worldwide.
For more information, visit:
www.pharmaxnext.com
Reach us on WhatsApp